Lixia Li
-
- Parkinson's Disease Mechanisms and Treatments 3
-
- Herpesvirus Infections and Treatments 3
- Liver Disease Diagnosis and Treatment 3
-
- Acupuncture Treatment Research Studies 4
-
- Cardiac, Anesthesia and Surgical Outcomes 4
- Cardiovascular Health and Disease Prevention 3
-
- Cerebrovascular and Carotid Artery Diseases 3
-
- Alzheimer's disease research and treatments 3
- Partner nations
- ChinaUnited StatesAustria
In The Last Decade
Lixia Li
45 papers receiving 508 citations
Peers
Comparison fields: 5 of 100
- Neurology 79
- Critical Care and Intensive Care Medicine 21
- Hepatology 30
- Epidemiology 130
- Complementary and alternative medicine 29
Countries citing papers authored by Lixia Li
This map shows the geographic impact of Lixia Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixia Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixia Li more than expected).
Fields of papers citing papers by Lixia Li
This network shows the impact of papers produced by Lixia Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixia Li. The network helps show where Lixia Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lixia Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 13 | |
| 10 | 2022 | 9 | |
| 11 | 2021 | 2 | |
| 12 | 2020 | 24 | |
| 13 | 2018 | 50 | |
| 14 | 2018 | 1 | |
| 15 | 2015 | 13 | |
| 16 | 2015 | 1 | |
| 17 | 2014 | 11 | |
| 18 | 2013 | 25 | |
| 19 | A controlled comparison study on paliperidone extended-release tablets and olanzapine in the treatment of schizophrenia | 2012 | 3 |
| 20 | A study of aripiprazole combined with clozapine in refractory schizophrenia | 2007 | 4 |
About Lixia Li
Lixia Li is a scholar working on Epidemiology, Neurology and Anesthesiology and Pain Medicine, having authored 54 papers that have together received 516 indexed citations. Recurring topics across this work include Cardiac, Anesthesia and Surgical Outcomes (4 papers), Acupuncture Treatment Research Studies (4 papers), Cerebrovascular and Carotid Artery Diseases (3 papers), Herpesvirus Infections and Treatments (3 papers), Parkinson's Disease Mechanisms and Treatments (3 papers), Alzheimer's disease research and treatments (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Cardiovascular Health and Disease Prevention (3 papers). The work is most often cited by research in Neurology (79 citations), Critical Care and Intensive Care Medicine (21 citations) and Hepatology (30 citations). Lixia Li has collaborated with scholars based in China, United States and Austria. Frequent co-authors include Peng Guo, Lijun Zuo, Yanhui Gao, Shouyan Zhang, Jing Yuan, Yang Hu, Linghua Li, Ruidan Wang, Shuyang Yu and Weiping Cai.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.